Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities

Figure 1

Determination of apoptosis based on morphological features. Four treatment groups: control (CTL); 40 μM dexamethasone (DXM) for 8 h; 100 μM temozolomide (TMZ) for 6 h; pretreatment with 40 μM DXM for 2 h followed by 100 μM TMZ for 6 h. (A) DXM prevented TMZ mediated decrease in U87MG cell viability. The trypan blue exclusion assay was used to assess cell viability in U87MG cells. (B) Photomicrographs showing representative cells from each treatment group. The arrows indicate apoptotic cells. (C) Bar graphs indicating the percentage of apoptotic cells counted from each group. Significant difference between CTL and TMZ treated cells was indicated by * (P ≤ 0.05) and significant difference between TMZ treated cells and DXM plus TMZ treated cells was indicated by # (P ≤ 0.05).

Back to article page

Molecular Cancer

ISSN: 1476-4598